CHINA NATIONAL MEDICINES

China National Medicines holds steady in a volatile market, trading flat yet showing measured growth and disciplined capital use amid regulatory tightening.

China National Medicines trading shows steady growth, a 5.7% rise in price and CNY 20.3 bn market cap, amid a tech‑driven recovery in China’s healthcare sector.

China National Medicines (600511.SS) shows flat trading but a 2.44% YTD gain, trading near CNY 27.62 with strong 52‑week range, plus a snapshot of peer performance.